Increased expression of TG2 in ovarian cancer cells enhanced their adhesion to fibronectin and promoted directional cell migration, whereas knockdown of TG2 showed diminished tumor dissemination on the peritoneal surface and in mesentery in an intraperitoneal ovarian xenograft mouse model [41]–[44]. Here, TGM2 is linked to ovarian carcinoma.